semaglutide and breast cancer GLP-1 medications may offer benefits beyond weight loss diabetes management, including improved outcomes for patients who are obese or have type 2 diabetes, according to new research. The study Women taking GLP-1 drugs may
Description
Semaglutide is not recommended during pregnancy, and women of childbearing potential should discontinue the medication at least two months before planned conception
Treatment of type 2 diabetes mellitus: Retatrutide is also being evaluated for glycemic control in patients with type 2 diabetes
Insulin for the treatment of women with gestational diabetes
All trials revealed cardiovascular safety by establishing non-inferiority
